Xia et al. demonstrated that NEK2 enhances MM cell autophagy by stabilizing Beclin1, and a combination of autophagy inhibitor CQ and bortezomib significantly prevents NEK2-induced drug resistance in MM cells [143]. Here, NEK2 is linked to Miyoshi myopathy.